Accès ouvert
2026
erratum
OpenAlex
Qonita Kurnia Anjani, Anjali Pandya, Sara Demartis, Juan Domínguez-Robles et autres
gb, it, es, co, in
(code pays fourni par la source)
Accès ouvert
2026
erratum
OpenAlex
Ismaiel A. Tekko, Gaoyun Chen, Juan Domínguez‐Robles, Raghu Raj Singh Thakur et autres
sy, gb, jo
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Jiawen Wang, Yaocun Li, Ross Duncan, Deepa Chaturvedi et autres
Onychomycosis is a prevalent and therapeutically challenging fungal infection, largely due to the highly keratinised nail plate that severely restricts drug penetration. Voriconazole (VCZ) is a broad-spectrum antifungal agent; however, its poor aqueous solubility and limited permeability hinder its use in topical …
gb, pt
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Lalitkumar K. Vora, B.H. Jaswanth Gowda, Jordan Strauss, Akeemat Tijani et autres
Biologics, including peptides, proteins, antibodies, vaccines and nucleic acid-based therapeutics, have transformed the management of chronic, metabolic, inflammatory, oncological and infectious diseases. Despite their clinical success, their wider use remains constrained by invasive administration routes, poor patient acceptability and formulation challenges related …
gb, in, us, fr
(code pays fourni par la source)
2026
article
OpenAlex
Qisty Saufa Alif, Prastika Krisma Jiwanti, Mirza Ardella Saputra, Qonita Kurnia Anjani et autres
id, gb, jp
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Camila J. Picco, Emilia Utomo, Elizabeth R. Magill, Qonita Kurnia Anjani et autres
Chronic conditions are increasingly prevalent worldwide, with the oral route being the most common for drug administration. However, limitations such as low bioavailability and patient nonadherence can result in complications that affect the patient's quality of life and increase healthcare costs. In …
gb, il, es
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Stephen A. Kelly, Li Zhao, Jonathan Nzakizwanayo, Aoife M. Rodgers et autres
Antibiotics cause significant gut microbiome dysbiosis, particularly when administered orally. This contributes to antimicrobial resistance (AMR) and is associated with myriad health conditions. Novel drug delivery strategies that minimize gut exposure while maintaining therapeutic efficacy are urgently needed. This study aimed to …
gb, ie
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
B.H.Jaswanth Gowda, Anjali Pandya, Shilpkala Gade, Ross Duncan et autres
Fungal keratitis (FK) is a leading cause of corneal blindness worldwide. Although voriconazole (VOR) is effective, its poor corneal permeability limits its topical use, whereas intrastromal injections are invasive and risky. Over the past 9 years, dissolving microneedle array patches (dMAPs) has …
in, gb
(code pays fourni par la source)
2026
erratum
OpenAlex
Rahul Nadda, Diganta Bhusan Das, Tahir Emre Yalcın, Abraham M. Abraham et autres
gb, tr
(code pays fourni par la source)
2026
article
OpenAlex
Andang Miatmoko, Qonita Kurnia Anjani, Rifda Tarimi Octavia, Natalia Porfiryeva et autres
id, gb, kr
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Jiachi Zhou, Lei Wu, Minna Wyttenbach, Ray Lennon et autres
Microneedle (MN) devices provide a platform for development of products that can facilitate intra-and trans-dermal delivery and sampling of active pharmaceutical ingredient (APIs) and biomarkers that would otherwise be restricted by the skin barrier. Despite significant progress in the development of laboratory-based …
us, de, kr, gb, au
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Ravi Prakash, Rahul Nadda, Abraham M. Abraham, Tahir Emre Yalcın et autres
This study presents an experimental–numerical framework integrated with Bayesian optimisation (BO) for the design of hollow pyramidal microneedle (MN) arrays to enhance transdermal drug permeability across the skin. Finite element (FE) simulations have been carried out to model coupled fluid flow and …
gb
(code pays fourni par la source)